Aarkstore - Anthrax - Pipeline Review, H1 2015

1. Aarkstore - Anthrax - Pipeline Review, H1 2015 www.aarkstore.com

2. Summary Global Markets Directs, “Anthrax - Pipeline Review, H1 2015”, provides an overview of the Anthraxs therapeutic pipeline. This Market Research Report provides comprehensive information on the therapeutic development for Anthrax, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anthrax and special features on late stage and discontinued projects. www.aarkstore.com

3. Scope The report provides a snapshot of the global therapeutic landscape of Anthrax The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Anthrax and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects A review of the Anthrax products under development by companies and universities/research institutes based on information derived from company and industry-specific sources Pipeline products coverage based n various stages of development ranging from pre-registration till discovery and undisclosed stages www.aarkstore.com

4. Reasons to buy Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage Develop strategic initiatives by understanding the focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Anthrax Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Anthrax pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline www.aarkstore.com

5. Table of Contents Introduction 8 Global Markets Direct Report Coverage 8 Anthrax Overview 9 Therapeutics Development 10 Pipeline Products for Anthrax - Overview 10 Pipeline Products for Anthrax - Comparative Analysis 11 Anthrax - Therapeutics under Development by Companies 12 Anthrax - Therapeutics under Investigation by Universities/Institutes 16 Anthrax - Pipeline Products Glance 17 Late Stage Products 17 Clinical Stage Products 18 Early Stage Products 19 www.aarkstore.com

6. List Of Tables Number of Products under Development for Anthrax, H1 2015 13 Number of Products under Development for Anthrax - Comparative Analysis, H1 2015 14 Number of Products under Development by Companies, H1 2015 16 Number of Products under Development by Companies, H1 2015 (Contd..1) 17 Number of Products under Development by Companies, H1 2015 (Contd..2) 18 Number of Products under Investigation by Universities/Institutes, H1 2015 19 Comparative Analysis by Late Stage Development, H1 2015 20 Comparative Analysis by Clinical Stage Development, H1 2015 21 Comparative Analysis by Early Stage Development, H1 2015 22 Products under Development by Companies, H1 2015 23 www.aarkstore.com

7. List Of Figures Number of Products under Development for Anthrax, H1 2015 13 Number of Products under Development for Anthrax - Comparative Analysis, H1 2015 14 Number of Products under Development by Companies, H1 2015 15 Number of Products under Investigation by Universities/Institutes, H1 2015 19 Comparative Analysis by Late Stage Development, H1 2015 20 Comparative Analysis by Clinical Stage Development, H1 2015 21 Comparative Analysis by Early Stage Products, H1 2015 22 Assessment by Monotherapy Products, H1 2015 60 Number of Products by Top 10 Targets, H1 2015 62 Number of Products by Stage and Top 10 Targets, H1 2015 62 www.aarkstore.com

8. Related Market Research reports: • Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2015 • Hyperphosphatemia - Pipeline Review, H1 2015 • H3N2 Infection - Pipeline Review, H1 2015 • Cough - Pipeline Review, H1 2015 • Alopecia - Pipeline Review, H1 2015 www.aarkstore.com

9. Related Market Research reports: • Anthrax - Pipeline Review, H1 2015 • Degenerative Disc Disease - Pipeline Review, H1 2015 • Male Infertility - Pipeline Review, H1 2015 • Women Infertility - Pipeline Review, H1 2015 • Nasopharyngeal Cancer - Pipeline Review, H1 2015 www.aarkstore.com

10. Aarkstore - Anthrax - Pipeline Review, H1 2015 www.aarkstore.com

11. Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon,  Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614,  Maharashtra, India. 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit : http://www.aarkstore.com OR Mail us at : contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news www.aarkstore.com